These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27861525)

  • 1. Elevated Neopterin Levels Are Associated with Increased Tuberculosis Risk in Rheumatoid Arthritis Patients with QuantiFERON Conversion during Biologic Therapy.
    Chen DY; Li JP; Chen YM; Liao TL; Chen HH; Hsieh CW; Yeh YW; Lan JL
    PLoS One; 2016; 11(11):e0166301. PubMed ID: 27861525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.
    Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY
    Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy.
    Chen DY; Shen GH; Hsieh TY; Hsieh CW; Lan JL
    Arthritis Rheum; 2008 Jun; 59(6):800-6. PubMed ID: 18512714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNFα inhibitors: the utility of IFNγ assay.
    Chen DY; Shen GH; Chen YM; Chen HH; Hsieh CW; Lan JL
    Ann Rheum Dis; 2012 Feb; 71(2):231-7. PubMed ID: 22021896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QuantiFERON-TB Gold in the identification of latent tuberculosis infection in rheumatoid arthritis: a pilot study.
    Shovman O; Anouk M; Vinnitsky N; Arad U; Paran D; Litinsky I; Caspi D; Elkayam O
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1427-32. PubMed ID: 19861018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases.
    Hatzara C; Hadziyannis E; Kandili A; Koutsianas C; Makris A; Georgiopoulos G; Vassilopoulos D
    Ann Rheum Dis; 2015 Oct; 74(10):1848-53. PubMed ID: 24854354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritis.
    Igari H; Ishikawa S; Nakazawa T; Oya Y; Futami H; Tsuyuzaki M; Suzuki K; Matsumura R
    J Infect Chemother; 2018 Feb; 24(2):110-116. PubMed ID: 29054459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The conversion rate of tuberculosis screening tests during biological therapies in patients with rheumatoid arthritis.
    Cuomo G; D’Abrosca V; Iacono D; Pantano I
    Clin Rheumatol; 2017 Feb; 36(2):457-461. PubMed ID: 27817127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of QuantiFERON-TB Gold and the tuberculin skin test for detecting previous tuberculosis infection evaluated by chest CT findings in Japanese rheumatoid arthritis patients.
    Maeda T; Banno S; Maeda S; Naniwa T; Hayami Y; Watanabe M; Sato S; Ueda R
    J Infect Chemother; 2011 Dec; 17(6):842-8. PubMed ID: 21528382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
    Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
    J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon gamma assay for detecting latent tuberculosis infection in rheumatoid arthritis patients during infliximab administration.
    Takahashi H; Shigehara K; Yamamoto M; Suzuki C; Naishiro Y; Tamura Y; Hirohashi Y; Satoh N; Shijubo N; Shinomura Y; Imai K
    Rheumatol Int; 2007 Oct; 27(12):1143-8. PubMed ID: 17503048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative utility of interferon-γ release assay, QuantiFERON
    Matsumura R; Igari H; Nakazawa T; Ishikawa S; Tsuyuzaki M; Suzuki K; Yamagishi F
    Int J Tuberc Lung Dis; 2016 Nov; 20(11):1546-1553. PubMed ID: 27776599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QuantiFERON-TB Gold In-Tube assay for screening arthritis patients for latent tuberculosis infection before starting anti-tumor necrosis factor treatment.
    Lee H; Park HY; Jeon K; Jeong BH; Hwang JW; Lee J; Cha HS; Koh EM; Kang ES; Koh WJ
    PLoS One; 2015; 10(3):e0119260. PubMed ID: 25746854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness and limitations of QuantiFERON-TB Gold in Japanese rheumatoid arthritis patients: proposal to decrease the lower cutoff level for assessing latent tuberculosis infection.
    Maeda T; Banno S; Maeda S; Naniwa T; Hayami Y; Watanabe M; Itoh R; Sato S; Ueda R
    Mod Rheumatol; 2010 Feb; 20(1):18-23. PubMed ID: 19779763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive conversion of interferon-γ release assay in patients with rheumatic diseases treated with biologics.
    Kim HW; Kwon OC; Han SH; Park MC
    Rheumatol Int; 2020 Mar; 40(3):471-479. PubMed ID: 31919575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA.
    Cho H; Kim YW; Suh CH; Jung JY; Um YJ; Jung JH; Kim HA
    Lupus; 2016 Oct; 25(12):1341-8. PubMed ID: 26985011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Significance of Sensitive Interferon Gamma Release Assays for Diagnosis of Latent Tuberculosis Infection in Patients Receiving Tumor Necrosis Factor-α Antagonist Therapy.
    Jung YJ; Woo HI; Jeon K; Koh WJ; Jang DK; Cha HS; Koh EM; Lee NY; Kang ES
    PLoS One; 2015; 10(10):e0141033. PubMed ID: 26474294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.
    Dyrhol-Riise AM; Gran G; Wentzel-Larsen T; Blomberg B; Haanshuus CG; Mørkve O
    BMC Infect Dis; 2010 Mar; 10():57. PubMed ID: 20210999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.